Atorvastatin normalizes endothelial function in healthy smokers

Clinical Science

Volumn 111, Issue 1, 2006, Pages 87-91

  Agewall, Stefan ^a   Hernberg, Âsa ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atherosclerosis; Cholesterol; Endothelial function; Intima media thickness; Lipoprotein; Smoking; Statin

Indexed keywords

ATORVASTATIN; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; VASODILATATION;

ADULT; BRACHIAL ARTERY; CHOLESTEROL, LDL; CROSS-OVER STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPIDS; MALE; PYRROLES; SMOKING; VASODILATION;

EID: 33745790710     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20060033     Document Type: Article

References (31)

1. Shepherd, J., Cobbe, S. M., Porj, I. et al. (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N. Engl. J. Med. 333, 1301-1307
2. Scandinavian Simvastatin Survival Study (4S) (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet 344, 1383-1389
3. Schwartz., G. G., Olsson, A. G., Ezekowitz, M. D. et al. (2001) Effects of atorvastatm on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA, J. Am. Med. Assoc. 285, 1711-1718
4. Hodis, H. N., Mack, W. J., LaBree, L. et al. (1996) Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomised controlled clinical trial. Ann. Intern. Med. l24, 548-556
5. Waters, D., Higginson, L., Gladstone, P. et al. (1994) Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial. Circulation 89, 959-968
6. Pitt, B., Mancini, G. B., Ellis, S. G., Rosman, H. S., Park, J. S and McGovern, M. E. (1995) Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atheroscerotic progression and clinical events. J. Am. Coll. Cardiol. 26, 1133-1139
7. Furchgott, R. F. and Zawadzki, J. V. (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (London) 299, 373-376
8. Celermajer, D. S., Sorensen, K. K., Georgakopoulus, D. et al. (1993) Cigarette smoking is associated with dose-related and potentially reversible impairment of endothclium-dependent dilatation in healthy young adults. Circulations 88, 2149-2155
9. Leung, W. H., Lau, C. P. and Wong, C. K. (1993) Beneficial effect of cholesterol-lowering therapy on coronary endothehum-dependent relaxation in hypercholesterolacmic patients. Lancet 341, 1496-1500
10. O'Driscoll, G., Green, D. and Taylor, R. R. (1997) Simvastatin, an HMG-coenzyme A reductase inhibitor, improves cndothelial function within 1 month. Circulation 95, 1126-1131
11. Kgashira, K., Hirooka, Y., Kai, H. et al. (1994) Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 89, 2519-2524
12. Beishuizen, K. D., Tamsma, J. T., Jukema, J. W. et al. (2005) The effect of statin therapy on endothelial function in tvpe 2 diabetes without manifest cardiovascular disease. Diabetes Care 28, 1668-1674
13. Balletshofer, B. M., Goebbel, S., Rittig, K., et al. (2005) Intense cholesterol lowering therapy with a HMG-CoA reductase inhibitor does not improve nitric oxide dependent endothelial function in type-2-diabetes: a multicenter, randomised, double-blind, three-arm placebo-controlled clinical trial. Exp. Clin. Kndocrinol. Diabetes 113, 324-330
14. Laufs, U., La Fata, V., Plutzky, J. and Liao, J. K. (1998) Upregulation of endothelial nitric oxide synthase by HMG CoA reductase. Circulation 97, 1129-1135
15. Kaesemeyer, W. H., Caldwell, R. B., Huang, J. and Caldwell, R. W. (1999) Pravastatin sodium activates endothelial nitic oxide synthase independent of its cholesterol-lowering actions. J. Am. Coll. Cardiol. 33, 234-241
16. Stamatelopoulos, K. S., Lekakis, J. P., Papamichael, C. M., Papaioannou, T. G., Cimboneriou, A. and Stamatelopoulos, S. F. (2003) Oral administration of ascorbic acid attenuates endothelial dysfunction after short-term cigarette smoking. Int. J. Vitam. Nutr. Res. 73, 417-422
17. Adams, M. R., Jessup, W. and Celermajer, D. S. (1997) Cigarette smoking is associated with increased human monocyte adhesion to endothelial cells: reversibility with oral L-arginine but not with vitamin C. J. Am. Coll. Cardiol. 29, 491-497
18. Agewall, S., Henareh, L. and Jogestrand, T. (2005) Intima-media complex of both the brachial artery and the common carotid artery are associated with left ventricular hypertrophy in patients with previous myocardial infarction. J. Hypertens. 23, 119-125
19. Agewall, S., Wright, S., Doughty, R. N., Whalley, G. A., Duxbury, M. and Sharpe, N. (2000) Does a glass of red wine improve the endothelial function? Eur. Heart J. 21, 1482-1483
20. Wendelhag, I., Leang, Q., Gustavsson, T. and Wikstrand, J. (1997) A new automated computerized analysing system simplifies reading and reduces the variability in ultrasound measurements of intima-media thickness. Stroke 28, 2195-2200
21. Sorensen, K. E., Celermajer, D. S., Spiegelhalter, D. J. et al. (1995) Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br. Heart J. 74, 247-253
22. Sorensen, K. E., Kristensen, I. B. and Celermajer, D. S. (1997) Atherosclerosis in the human brachial artery. J. Am. Coll. Cardiol. 29, 318-322
23. Wiesmann, F., Petersen, S. E., Leeson, P. M. et al. (2004) Global impairment of brachial, carotid, and aortic vascular function in young smokers: direct quantification by high-resolution magnetic resonance imaging. J. Am. Coll. Cardiol. 44, 2056-2064
24. Rohani, M. and Agewall, S. (2004) Oral snuff impairs endothelial function in healthy middle-aged snuff users. J. Intern. Med. 255, 379-383
25. Neunteufl, T., Heher, S., Kostner, K. et al. (2002) Contribution of nicotine to acute endothelial dysfunction in long-term smokers. J. Am. Coll. Cardiol. 39, 251-256
26. Murohara, T., Kugiyama, K., Oghushi, M., Sugiyama, S. and Yasue, H. (1994) Cigarette smoke extract contracts isolated porcine coronary arteries by Superoxide anion-mediated degradation of EDRF. Am. J. Physiol. 273, H874-H880
27. Papamichael, C., Karatzis, E., Karatzi, K. et al. (2004) Red wine's antioxidants counteract acute endothelial dysfunction caused by cigarette smoking in healthy nonsmokers. Am. Heart J. 147, e5
28. Craig, W. Y., Palomaki, G. E. and Haddow, J. E. (1989) Cigarette smoking and serum lipid and lipoprotem concentrations: An analysis of published data. Br. Med. J. 298, 784-788
29. Gokce, N., Keaney, Jr, J. F., Hunter, L. M., Watkins, M. T., Menzoian, J. O. and Vita, J. A. (2002) Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation 105, 1567-1572
30. Neunteufl, T., Heher, S., Katzenschlager, R., Wolfl, G., Kostner, K. and Maurer, G. (2000) Late prognostic value of flow-mediated dilatation in the brachial artery of patients with chest pain. Am. J. Cardiol. 86, 207-210
31. Beckman, J. A., Liao, J. K., Hurley, S. et al. (2004) Atorvastatm restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein. Circ. Res. 95, 217-223